The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis. [electronic resource]
Producer: 20201204Description: 45-54 p. digitalISSN:- 1618-7601
- Cost-Benefit Analysis
- Female
- Humans
- Injections, Subcutaneous
- Male
- Markov Chains
- Models, Econometric
- Quality-Adjusted Life Years
- Severity of Illness Index
- Spondylitis, Ankylosing -- drug therapy
- Tumor Necrosis Factor Inhibitors -- administration & dosage
- United Kingdom
- Assessment of Medication Adherence
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.